Satellite Bio Email Format

Biotechnology ResearchMassachusetts, United States11-50 Employees

Satellite Bio operates in biotechnology research with a focus on regenerative medicine through Tissue Therapeutics, an approach aimed at addressing diseases that are difficult to treat with conventional therapies. Its SAT platform can convert a wide range of cell types into bioengineered tissues that are designed to be integrated into the body to restore natural function. These tissues, referred to as Satellites, are intended to deliver the full cellular responses needed to repair or replace critical organ functions affected by the interaction of genetic and environmental factors. The technology is described as enabling a pipeline of cell-based therapeutic solutions targeting a broad set of elusive diseases.

The company is based in Cambridge, Massachusetts, and functions within the biotechnology research industry. In January 2026, Satellite Bio announced the appointment of Steven Altschuler as chair of its board, marking a governance development.

Sign up for free to view info

Company overview Employee directory